Breaking News

MHRA warns against using Midazolam while GMC encourages its use to treat Covid

Print Friendly, PDF & Email

“What people in the [UK], and indeed international viewers, may be interested to know is that our MHRA … issued advice on benzodiazepine and opioids in March 2020, just before this guidance from NICE came out, and it’s diametrically opposed to this NICE guidance,” Clare Wills Harrison said.

Wills Harrison, a UK lawyer, has several legal cases where midazolam has clearly been misused.  Midazolam seems to have been used in the UK the same way as remdesivir has been used in the USA so last week Dr. Bryan Ardis interviewed Wills Harrison.

As the interview covers a great deal of important information, we are taking extracts and publishing them in a series of articles.  This article is the second in the series, the first can be read HERE.  You can watch the full 90-minute discussion ‘UK Attorney, Clare Wills-Harrison, exposes “End of Life” drugs, protocolsHERE.

In March 2020, the UK’s Medicines and Healthcare products Regulatory Agency (“MHRA”) issued a reminder of the risk of potentially fatal respiratory depression when benzodiazepines and opioids are used stating:

“We remind healthcare professionals that benzodiazepines and benzodiazepine-like drugs and opioids can both cause respiratory depression. When co-prescribed, the depressive effect on the central nervous system is additive. Therefore, they should only be co-prescribed if there is no alternative. Warnings about the risks of co-prescribing these products were reviewed in Europe in 2018.”

The words “reviewed in Europe in 2018” contain a link to a document from the Co-ordination Group for Mutual Recognition and Decentralised Procedures  – Human (“CMDh”).  The opening paragraph reads:

The 18 March 2020 MHRA guidance also notes the advice to be given to patients which includes: “For benzodiazepines or related drugs and opioids, the patient information leaflet advises that these medicines increase the risk of drowsiness, difficulties in breathing (respiratory depression), and coma, and that these effects may be life-threatening.”

Despite MHRA’s warnings, a few weeks later, on 3 April 2020, NICE advised clinicians that benzodiazepine and opioids could be used as a treatment for Covid.

“It gets worse as far as I’m concerned,” said Wills Harrison, highlighting a statement from the General Medical Council (“GMC”) on 14 April 2020 which stated:

“We want practitioners to know that it is entirely appropriate to follow these guidelines and that we would not have concerns about prescribing decisions based upon them.”

Despite benzodiazepine and opioids not having a UK marketing authorisation for this purpose and despite the MHRA’s warning in March, the GMC does not seem to have any concerns, said Wills Harrison.  Instead, GMC’s document says:

“‘Sufficient evidence’.  I suggest there wasn’t, two weeks into the so-called ‘pandemic’, sufficient evidence of that drug combination working,” Wills Harrison said, adding that regarding “sufficient information,” as is the case in the USA, there has been and is no informed consent.

Wills Harrison highlighted further key points in the GMC’s statement which are very disturbing.  “They clearly state that sedation and opioid use should not be withheld for fear of causing respiratory depression,” she said.

The GMC statement also stated: “We want practitioners to know that it is entirely appropriate to follow these guidelines and that we would not have concerns about prescribing decisions based upon them.”

“So, you have: possibly inexperienced practitioners, possibly people in a panic because of the narrative that’s coming out of the media and they’ve got a green light to prescribe this medication … it’s a green light to use midazolam and morphine, or other opioids, in this way,” said Wills Harrison.

There is no anti-viral benefit from either midazolam or morphine yet these are the two drugs that were being advised to be used for Covid, a respiratory illness.

The Dr. Ardis Show: Clare Wills Harrison, MHRA and GMC Advice, 17 January 2022 (7 mins)

Resources:

Share this page to Telegram

Categories: Breaking News

Tagged as:

5 2 votes
Article Rating
Subscribe
Notify of
guest

6 Comments
Inline Feedbacks
View all comments
Stephen Smith
Stephen Smith
10 months ago

They want to repeat what they did in 2020. They ‘helped’ many oaps to their graves in order to end their suffering. They used twice the yearly norm of midazolam that year and apparently they have extra ordered again.

Epicurious
Epicurious
10 months ago

If NICE and MHRA are two government bodies arguing opposing views then surely someone at the top is negligent in not having the two co-ordinate their “guidance” to practitioners or separately taking responsibility and giving advice directly to said practitioners. Want to confuse things, then use a bureaucrat.

trackback
10 months ago

[…] of articles.  This article is the third in the series, follow the links to read Part 1 and Part 2.  You can also watch the full 90-minute discussion ‘UK Attorney, Clare Wills-Harrison, […]

Gary
Gary
10 months ago

Interesting. Clearly it’s premeditated murder.
Was wondering though, the MHRA wasn’t around in 2020. It was only set up in 2021. Before that Public Health England were dealing with such issues. Is that the group you meant ?

trackback
10 months ago

[…] 00:31:33 MHRA and GMC advice on using benzodiazepine and opioids (Part 2) […]